Charles River Endosafe® Nexus™ Automated Endotoxin Testing System

Overview

The Charles River Endosafe® Nexus™ Automated Endotoxin Testing System is an FDA-cleared, fully integrated platform engineered for precision, reproducibility, and regulatory compliance in bacterial endotoxin quantification using the Limulus Amebocyte Lysate (LAL) assay. It implements kinetic chromogenic LAL methodology—based on the enzymatic cascade triggered by endotoxin in horseshoe crab lysate—to deliver quantitative results with high sensitivity (down to 0.005 EU/mL) and traceable calibration against the USP Reference Standard. Unlike manual or semi-automated workflows, the Nexus™ system eliminates operator-dependent variables at every critical step: reagent dispensing, sample dilution, incubation timing, optical density measurement, and standard curve generation. Its closed-tube, single-use cartridge architecture prevents carryover contamination and ensures assay integrity across high-throughput environments such as QC release testing, stability studies, and aseptic process validation.

Key Features

• Fully automated end-to-end workflow: From sample loading to final report generation—including automatic serial dilution, reagent addition, temperature-controlled incubation (37 ± 0.5 °C), and real-time absorbance monitoring at 405 nm.
• Pre-qualified, single-use test cartridges: Each cartridge contains lyophilized LAL reagent, controls, and calibrated standards—eliminating manual reconstitution, pipetting errors, and inter-batch variability.
• Integrated audit trail and electronic signature capability compliant with 21 CFR Part 11 requirements: All user actions, instrument events, calibration logs, and result modifications are time-stamped, immutable, and attributable.
• Intuitive touchscreen interface with role-based access control: Supports multiple user levels (Analyst, Supervisor, Administrator) aligned with GLP/GMP responsibilities.
• Onboard data validation engine: Automatically flags outliers, non-linear standard curves, control failures, and out-of-specification (OOS) results per predefined acceptance criteria (e.g., USP <85>, EP 2.6.14).
• Modular scalability: Configurable for 1–96 samples per run; compatible with laboratory information management systems (LIMS) via ASTM E1384-compliant HL7 or CSV export.

Sample Compatibility & Compliance

The Endosafe® Nexus™ accommodates a broad range of pharmaceutical and biotechnology matrices—including parenteral drugs, vaccines, medical device rinsates, water-for-injection (WFI), and cell culture media—without requiring matrix-specific method adjustments. All assays are validated per ICH Q2(R2) guidelines for specificity, linearity, accuracy, precision, and robustness. The system meets essential regulatory expectations for endotoxin testing under USP <85>, European Pharmacopoeia 2.6.14, Japanese Pharmacopoeia 4.03, and FDA Guidance for Industry (2022). Instrument qualification follows IQ/OQ/PQ protocols aligned with ASTM E2500-13, and routine performance verification includes daily system suitability testing (SST) with certified reference standards traceable to NIST SRM 21–10.

Software & Data Management

Endosafe® Nexus™ operates on proprietary firmware with embedded software version 5.2 or later, supporting full ALCOA+ data integrity principles. Raw absorbance data, kinetic reaction curves, and calculated endotoxin concentrations are stored in encrypted SQLite databases with automatic daily backup to network drives. Reporting modules generate PDF/CSV outputs compliant with Annex 11 and GAMP 5 requirements, including full metadata (sample ID, analyst, timestamp, instrument ID, cartridge lot, environmental conditions). Software updates are delivered via secure, signed packages with version-controlled change logs and impact assessments. Remote diagnostics and service support are enabled through TLS 1.2–secured connections—no inbound internet exposure required.

Applications

• Final product release testing of injectables, ophthalmic solutions, and implantable devices.
• In-process monitoring during aseptic manufacturing and filter integrity validation.
• Stability-indicating assays for shelf-life determination per ICH Q5C.
• Raw material qualification (e.g., excipients, buffers, single-use system extracts).
• Environmental monitoring of cleanroom isolators and filling lines.
• Supporting comparability protocols for biosimilar development and post-approval changes.

FAQ

Is the Endosafe® Nexus™ system compliant with 21 CFR Part 11?
Yes—the system includes electronic signatures, audit trails, and data security controls validated to meet all applicable requirements of 21 CFR Part 11 and EU Annex 11.
Can the system be integrated into an existing LIMS or MES environment?
Yes—it supports structured data export via HL7, ASTM E1384, or delimited text formats, and can be configured for automated import into validated enterprise systems.
What validation documentation is provided with the instrument?
Charles River supplies comprehensive IQ/OQ/PQ protocols, system configuration specifications, and a Certificate of Conformance—alongside vendor-supported PQ execution services.
Does the system require routine calibration with external standards?
No—each disposable cartridge contains NIST-traceable reference standards; system verification is performed daily using built-in SST checks per USP <85>.
How is reagent stability managed across batches?
Lyophilized reagents in each cartridge are qualified for ≥12 months shelf life at 2–8 °C; lot-specific potency data and expiration tracking are embedded in cartridge RFID tags and enforced by the software.